Related Experiment Video
Updated: Jun 11, 2026
12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
pT0 prostate cancer after radical prostatectomy
Jenna L Gross1, Timothy A Masterson, Liang Cheng
1Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
Journal of Surgical Oncology
|July 1, 2010
Summary
This study reviewed data on pT0 prostate cancer after radical prostatectomy. Lower preoperative PSA, fewer positive biopsy cores, and a Gleason score under 7 were linked to pT0 findings.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Prostate cancer is a leading cause of cancer death in men.
- Radical prostatectomy is a primary treatment for localized prostate cancer.
- Pathological staging (pT) is crucial for treatment planning and prognosis.
Purpose of the Study:
- To determine the frequency of pT0 prostate cancer after radical prostatectomy.
- To identify clinical and pathological correlates associated with pT0 findings.
- To synthesize current literature on pT0 prostate cancer outcomes.
Main Methods:
- Literature review of MEDLINE and PUBMED databases.
- Inclusion of studies reporting pT0 prostate cancer after radical prostatectomy.
- Pooled analysis of data from identified studies.
Main Results:
- Seven studies involving 18,135 patients were analyzed.
- 74 cases of pT0 prostate cancer were reported.
- Frequent correlates of pT0 included preoperative PSA <10 ng/ml, one positive biopsy core, and Gleason score <7.
Conclusions:
- pT0 prostate cancer after radical prostatectomy is infrequent.
- Specific preoperative factors may predict pT0 findings.
- Further research is needed to understand the clinical significance of pT0 prostate cancer.
